Navigation Links
Naurex Names Dr. Norbert G. Riedel President and Chief Executive Officer
Date:1/8/2014

e at Boston University School of Medicine and adjunct professor of medicine at Northwestern University's Feinberg School of Medicine. Dr. Riedel received a Diploma and Ph.D. from the University of Frankfurt and was a postdoctoral fellow at Harvard University and a visiting professor at the Massachusetts Institute of Technology.

About Naurex
Naurex is a clinical-stage biopharmaceutical company developing products to treat diseases of the central nervous system (CNS). The company's lead compound, GLYX-13, has shown promising rapid-acting antidepressant activity with excellent safety and no psychcomimetic side effects in a Phase 2a clinical trial. GLYX-13 is currently in a Phase 2b repeat dose study as adjunctive therapy for major depressive disorder. Naurex's 2nd-generation antidepressant is in Phase 1 clinical trials. Naurex's proprietary platform is focused on discovering novel compounds that act at the NMDA receptor to modulate neuronal plasticity and hold therapeutic potential for a number of CNS indications. For more information, visit www.naurex.com.

Contacts:
Naurex Inc.
Ashish Khanna
Vice President, Corporate Development
T: 847-871-0377
corporate@naurex.com

Media and Investors
Russo Partners, LLC
Robert Flamm, Ph.D.                            
Matt Middleman, M.D.
T: 212-845-4226                                    
T: 212-845-4272

SOURCE Naurex Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Naurex Announces Issuance Of New Patent For Novel Antidepressant GLYX-13
2. DiversityInc Names Lilly a Top Company for Diversity
3. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
4. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
5. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
6. Bausch + Lomb Names John Barr Global President Surgical
7. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
8. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
9. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
10. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
11. MedVantx Names New VP Employer Solutions and Workplace Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)...  AbbVie (NYSE: ABBV ) has announced that ... its New Drug Application (NDA) and granted priority review ... of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The ... genotype 4 (GT4) hepatitis C virus (HCV) infection. ... being evaluated by the FDA for patients in ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
... Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company ... from its consumer trial with Allumera™, a breakthrough cosmetic ... The RevitAll study was performed with a standard ... Allumera™ improves skin appearance, when compared to exposure by ...
... Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and ... of women, announced today the U.S. Food and ... Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. ...
Cached Medicine Technology:Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 2Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 3Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 4FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical 2
(Date:4/26/2015)... Aliso Viejo, CA (PRWEB) April 26, 2015 ... Final Cut Pro X editors can quickly and ... a Lookup Table that contains a mathematical formula for modifying ... corresponding color indicated by the table. This pack comes with ... was inspired by vintage and contemporary black and white films. ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 This annual ... of the season and will include a spectacular collection ... totes, collectibles, herbal soaps and incense, chimes, vases, candleholders, ... this year’s exciting and unique collection of vendors, guests ... with Jim Martocci and the Jimmie Jazz Band. ...
(Date:4/26/2015)... Memphis, TN (PRWEB) April 26, 2015 ... plans to grow throughout the Southeast. MidSouth Pain Treatment ... clinic locations in Cordova, Southaven, Oxford and Jackson, two ... CLIA-certified laboratory in the Southaven and Cordova locations. , ... said ”I went into medicine to help people, ...
(Date:4/25/2015)... April 25, 2015 In observance of ... join The Million Nets Pledge, a two-year pledge by ... protect refugee families with one million bednets by 2016. ... work with UN partners to protect children, refugees, and ... , “There has been a large surge in ...
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post ... insurance for flatbed trucks. , Flatbed trucks ... vehicles. They are mainly used for commercial purposes and ... post explains that by comparing multiple offers, drivers can ... commercial vehicles. , It is now possible to compare ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2
... majority of advanced colon cancer patients in a clinical ... drugs for managing chemotherapy side effects, such as infection, ... drug cost burdens after joining the clinical trial, according ... Institute in Boston. Although few patients reported substantial worry ...
... -- PRA International, a leading Clinical Research ... audioconference and announces it will exhibit at the 2009 ... Florida, May 30 through June 1. The audioconference, which ... 2009, and was presented by John Constant, PhD, PRA,s ...
... U.S. Food and Drug Administration (FDA) announced today that ... for Pharmaceutical Science and Clinical Pharmacology to discuss bioequivalence ... The meeting is scheduled for August 4, 2009. ... no later than two days before the meeting at ...
... 29 The J. Craig Venter Institute (JCVI) announced ... five year contract from the National Institute of Allergy ... of Health, as one of their Genomic Sequencing Centers ... Nierman, Ph.D., and Robert Strausberg, Ph.D., the contract will ...
... DeterminedToQuit.com translated to Estoydecidido.com for Latino PennsylvaniansHARRISBURG, ... Health Everette James today announced the launch ... Latino residents of Pennsylvania go tobacco free.Estoydecidido.com ... - is the Spanish version of the ...
... finds student military veterans face some unique health issuesMINNEAPOLIS/ST. ... expected to go to school this fall as a ... will need to ensure student veterans, unique needs are ... issued Friday by the University of Minnesota ...
Cached Medicine News:Health News:One in ten advanced colon cancer patients worry about prescription drug costs 2Health News:PRA International Oncology Experts at ASCO 2Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 2Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 3Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 4Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 3Health News:PA Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3
... is now the first manufacturer to ... to the wearer. These next generation ... clarity, an ultra-lightweight design, and are ... scratch resistance. With SheerVision's proprietary SureFit ...
For face-lifts and submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Facial Mask...
Medicine Products: